Empirical equations were proposed for the prediction of the ambient dose equivalent rates from patients administered with radioiodine for the treatment of thyroid cancers. Ambient dose equivalent rates were measured for 59 patients who received high-dose I-131 treatment after thyroid ablation at different times after the administration. An ion chamber was used to measure the dose equivalent rates at 1 m away from the body and on contact to the thyroid of the patients. The resulting equations for estimating dose equivalent rates at 1 m from the body and on contact to the thyroid are, respectively, dot H(body)(1)0.236e(0.0501t) (mSv h(1) GBq(1)) and dot H(thy)(c)2.676e(0.0443t) (mSv h(1) GBq(1)). The effective half-times in total body appeare...
Radioiodine (131I iodide) has long been a safe, effective and widely used treatment in the managemen...
Radioiodine plays an important role in the treatment of thyroid cancer. It is used for thyroid remna...
Radioactive iodine 131I has been used for many years to treat benign thyroid disease. Treatment of t...
Patients treated with radioiodine present a radiation hazard and precautions are necessary to limit ...
an individually optimized dosimetry method for patients with thyroid carcinoma undergoing radioiodin...
Three days following administration of radioactive iodine in 38 patients, exposure rates such as dos...
The aim of this study was to determine the external dose rate of iodine retention as a function of t...
Radiation safety is an integral part of targeted radionuclide therapy. The aim of this work was to s...
Introduction In order to discharge the patients receiving treatment with large radiation doses of 13...
IntroductionRetained radioactivity of 131I after ablation therapy largely differs in each patient ac...
Accurate measurements of radiation dose are necessary if radiation treatment with I-131 is to be use...
Purpose: Effective half life of I-131 (Teff) in patients with differentiated thyroid cancer treated ...
International audiencePotassium iodide (KI) is a well-known thyroid prophylactic agent that blocks t...
The treatment for some thyroid carcinomas involves surgically removing the thyroid gland and adminis...
Hyperthyroid patients treated with radioiodine (I-131) pose an external radiation risk to individual...
Radioiodine (131I iodide) has long been a safe, effective and widely used treatment in the managemen...
Radioiodine plays an important role in the treatment of thyroid cancer. It is used for thyroid remna...
Radioactive iodine 131I has been used for many years to treat benign thyroid disease. Treatment of t...
Patients treated with radioiodine present a radiation hazard and precautions are necessary to limit ...
an individually optimized dosimetry method for patients with thyroid carcinoma undergoing radioiodin...
Three days following administration of radioactive iodine in 38 patients, exposure rates such as dos...
The aim of this study was to determine the external dose rate of iodine retention as a function of t...
Radiation safety is an integral part of targeted radionuclide therapy. The aim of this work was to s...
Introduction In order to discharge the patients receiving treatment with large radiation doses of 13...
IntroductionRetained radioactivity of 131I after ablation therapy largely differs in each patient ac...
Accurate measurements of radiation dose are necessary if radiation treatment with I-131 is to be use...
Purpose: Effective half life of I-131 (Teff) in patients with differentiated thyroid cancer treated ...
International audiencePotassium iodide (KI) is a well-known thyroid prophylactic agent that blocks t...
The treatment for some thyroid carcinomas involves surgically removing the thyroid gland and adminis...
Hyperthyroid patients treated with radioiodine (I-131) pose an external radiation risk to individual...
Radioiodine (131I iodide) has long been a safe, effective and widely used treatment in the managemen...
Radioiodine plays an important role in the treatment of thyroid cancer. It is used for thyroid remna...
Radioactive iodine 131I has been used for many years to treat benign thyroid disease. Treatment of t...